Review
BibTex RIS Cite

Türkiye’de Son 10 Yılda Hemşirelik Alanında Yapılan Oral Kemoterapi Konulu Makalelerin İncelenmesi

Year 2023, , 791 - 799, 15.10.2023
https://doi.org/10.38108/ouhcd.1263211

Abstract

Bu çalışmada, Türkiye’de hemşirelik alanında 2012-2023 yılları arasında yayımlanan oral kemoterapi konulu makalelerin incelenmesi amaçlanmıştır. Araştırma literatüre dayalı retrospektif tipte tanımlayıcı olarak yapılmıştır. Türkçe ve İngilizce olarak “oral kemoterapi”, “hemşirelik” anahtar kelimeleri kullanılarak Google Akademik, Türk Medline ve Pubmed veri tabanlarından araştırılmıştır. 2012-2023 yılları arasında yayımlanan ve dahil edilme kriterlerini karşılayan 11 makale incelenmiştir. Makalelerin %81.8’i araştırma makalesi ve %18.2’sinin derleme olduğu saptanmıştır. Makalelerin %54.5’i ulusal, %45.5’i ise uluslararası dergilerde ve %63.6’sı İngilizce olarak yayımlanmıştır. Araştırmaların %45.5’i oral kemoterapi de ilaç uyumunu incelemiştir. Araştırmaların %100’ü hastalar ile gerçekleştirilmiştir. Araştırmalarda örneklem popülasyonu olarak sağlık profesyonelleri ve hastalara bakım veren aile üyeleriyle yapılan çalışmalara ulaşılamamıştır. Hasta bakım kalitesi açısından bu grupların farkındalıkları, bilgi düzeyleri, klinik uygulamaları ve destek ihtiyaçlarının saptanmasının kanıt temelli çalışmalara yol gösterici olacağı düşünülmektedir.

References

  • Aisner J. (2007). Overview of the changing paradigm in cancer treatment: oral chemotherapy. American Journal of Health-System Pharmacy, 64(Suppl 5), 4–7. https://doi.org/10.2146/ajhp070035
  • Algethami AA, Alshamrani MA, AlHarbi AM, AlAzmi AA, Khan MA, AlHadidi RA. (2021). Evaluation of handling, storage, and disposal practices of oral anticancer medications among cancer patients and their caregivers at home setting in the Princess Noorah Oncology Center. Journal of Oncology Pharmacy Practice, 27(1), 20–25. https://doi.org/10.1177/ 1078155220908937
  • Bağçivan G, Akbayrak N. (2015). Development and psychometric testing of the Turkish-version oral chemotherapy adherence scale. The Journal of Nursing Research, 23(4), 243–251. https://doi.org/10.1097/ JNR.0000000000000101
  • Banna GL, Collovà E, Gebbia V, Lipari H, Giuffrida P, Cavallaro S et al. (2010). Anticancer oral therapy: emerging related issues. Cancer Treatment Reviews, 36(8), 595–605. https://doi.org/10.1016/j.ctrv.2010.04.005
  • Barillet M, Prevost V, Joly F, Clarisse B. (2015). Oral antineoplastic agents: how do we care about adherence?. British Journal of Clinical Pharmacology, 80(6), 1289–1302. https://doi.org/10.1111/bcp.12734
  • Chen Y, Wu X, Xian X, Zhang Y, Gong N, Qin H et al. (2020). Adherence to oral chemotherapy among colorectal cancer patients: a longitudinal study. European Journal of Oncology Nursing, 48, 101822. https://doi.org/10.1016/j.ejon.2020.101822
  • Christiansen N, Taylor KM, Duggan C. (2008). Oral chemotherapy in paediatric oncology in the UK: problems, perceptions and information needs of parents. Pharmacy World & Science, 30(5), 550–555. https://doi.org/10.1007/s11096-008-9208-5
  • Cin S, Karadakovan A. (2017). Oral kemoterapi tedavisi alan hastalara verilecek planlı eğitimin tedaviye uyma ve yaşam kalitesi üzerine etkisinin incelenmesi. E-Sağlık Hemşirelik Dergisi, 25(7), 10-19.
  • Cirillo M, Carlucci L, Legramandi L, Baldini E, Sacco C, Zagonel V et al. (2020). Oral anticancer therapy project: clinical utility of a specific home care nursing programme on behalf of Italian Association of Medical Oncology (AIOM). Journal of Clinical Nursing, 29(1-2), 119–129. https://doi.org/10.1111 /jocn.15064
  • Çakmak HS, Akdemir N. (2020). Knowledge and implication about oral antineoplastics drugs use of cancer patients. Turkish Journal of Clinics and Laboratory, 11(5), 387-392. https://doi.org/10.18663/tjcl.674152
  • Gandhi S, Day L, Paramsothy T, Giotis A, Ford M, Boudreau A et al. (2015). Oral anticancer medication adherence, toxicity reporting, and counseling: a study comparing health care providers and patients. Journal of Oncology Practice, 11(6), 498–504. https://doi.org/10.1200/JOP.2015.004572
  • Geynisman DM, Wickersham KE. (2013). Adherence to targeted oral anticancer medications. Discovery Medicine, 15 (83), 231-41.
  • Goodin S, Griffith N, Chen B, Chuk K, Daouphars M, Doreau C et al. (2011). Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panel. Journal of Oncology Practice, 7(1), 7–12. https://doi.org/10.1200/jop.2010.000068
  • Gönderen Çakmak HS, Kapucu S. (2021). The effect of educational follow-up with the motivational interview technique on self-efficacy and drug adherence in cancer patients using oral chemotherapy treatment: a randomized controlled trial. Seminars in Oncology Nursing, 37(2), 151140. https://doi.org/10.1016/j.soncn.2021.151140
  • Gönderen Çakmak HS, Kapucu S. (2018). Oral antikanser ilaç kullanan kanser hastalarında telefon ile yapılan izlemin ilaç uyumuna etkisi: sistematik derleme. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi, 5(3), 230-246. https://doi.org/10.31125/hunhemsire.500799
  • Gönderen Çakmak HS, Uncu D. (2020). Relationship between health literacy and medication adherence of Turkish cancer patients receiving oral chemotherapy. Asia-Pacific Journal of Oncology Nursing, 7(4), 365–369. https://doi.org/10.4103/apjon.apjon_30_20
  • Hirao C, Mikoshiba N, Shibuta T, Yamahana R, Kawakami A, Tateishi R et al. (2017). Adherence to oral chemotherapy medications among gastroenterological cancer patients visiting an outpatient clinic. Japanese Journal of Clinical Oncology, 47(9), 786–794. https://doi.org/10.1093/jjco/hyx087
  • Huff C. (2020). Oral chemotherapy: a home safety educational framework for healthcare providers, patients, and caregivers. Clinical Journal of Oncology Nursing, 24(1), 22–30. https://doi.org/10.1188/20.CJON.22-30
  • Irshad S, Maısey N. (2010). Considerations when choosing oral chemotherapy: identifying and responding to patient need. European Journal of Cancer Care, 19, 5–11.
  • Jacobs JM, Ream ME, Pensak N, Nisotel LE, Fishbein JN, MacDonald JJ et al. (2019). Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life. Journal of the National Comprehensive Cancer Network, 17(3), 221–228. https://doi.org/10.6004/jnccn.2018.7098
  • Johnson LA. (2015). Factors influencing oral adherence: qualitative metasummary and triangulation with quantitative evidence. Clinical Journal of Oncology Nursing, 19(Suppl 3), 6–30. https://doi.org/10.1188/15.S1.CJON.6-30
  • Kahn JM, Athale UH, Clavell LA, Cole PD, Leclerc JM, Laverdiere C et al. (2017). How variable ıs our delivery of information? Approaches to patient education about oral chemotherapy in the pediatric oncology clinic. Journal of Pediatric Health Care, 31(1), 1–6. https://doi.org/10.1016/j.pedhc.2016.06.004
  • Karaaslan Eşer A, Ayaz Alkaya S. (2021). The effect of a mobile application on treatment adherence and symptom management in patients using oral anticancer agents: a randomized controlled trial. European Journal of Oncology Nursing, 52, 101969. https://doi.org/10.1016/j.ejon.2021.101969
  • Krikorian S, Pories S, Tataronis G, Caughey T, Chervinsky K, Lotz M et al. (2019). Adherence to oral chemotherapy: challenges and opportunities. Journal of Oncology Pharmacy Practice, 25(7), 1590–1598. https://doi.org/10.1177/1078155218800384
  • Kutlutürkan S, Sözeri E. (2016). Oral kemoterapi uygulamasında anahtar unsur: hasta uyumu. Van Tıp Dergisi, 23(3), 290-293.
  • Kutlutürkan S, Yurtal Ö, Kırca K. (2018). Opinions and experiences of patients receiving oral chemotherapy: a qualitative study. Annals of Oncology, 29(8), 686. https://doi.org/10.1093/annonc/mdy276.014
  • Lin C, Clark R, Tu P, Bosworth HB, Zullig LL. (2017). Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers. Breast Cancer Research and Treatment, 165(2), 247–260. https://doi.org/10.1007/s10549-017-4317-2
  • Moore S. (2007). Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nursing, 30(2), 112–124. https://doi.org/10.1097/01.NCC.0000265009.33053.2d
  • Özkaraman A, Orlu N, Atalay HÖ, Babadağ B, Yılmaz H, Dinçer M ve ark. (2017). Oral kemoterapi alan hastalarda yaşanılan güçlükler ve ilaç uyumunun değerlendirilmesi. Bakırköy Tıp Dergisi, 13(2), 91-97. https://doi.org/10.5350/BTDMJB201713206
  • Shinnick S. (2020). Assessment of the role of the pediatric nurse in patient education and follow-up of patients receiving oral anticancer treatment. Journal of Pediatric Oncology Nursing, 37(1), 46–54. https://doi.org/10.1177/1043454219871081
  • Solano M, Daguindau E, Faure C, Loriod P, Pain C, Maes AC et al. (2021). Oral therapy adherence and satisfaction in patients with multiple myeloma. Annals of Hematology, 100(7), 1803–1813. https://doi.org/10.1007/s00277-021-04543-7
  • Sun J, Wei Q, Zhou Y, Wang J, Liu Q, Xu H. (2017). A systematic analysis of FDA-approved anticancer drugs. BMC Systems Biology, 11(Suppl 5), 87. https://doi.org/10.1186/s12918-017-0464-7
  • Talens A, Guilabert M, Lumbreras B, Aznar MT, López-Pintor E. (2021). Medication experience and adherence to oral chemotherapy: a qualitative study of patients' and health professionals' perspectives. International Journal of Environmental Research and Public Health, 18(8), 4266. https://doi.org/10.3390/ijerph18084266
  • Tokdemir G, Kav S. (2017). The effect of structured education to patients receiving oral agents for cancer treatment on medication adherence and self-efficacy. Asia-Pacific Journal of Oncology Nursing, 4(4), 290–298. https://doi.org/10.4103/apjon.apjon_35_17
  • Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM et al. (2008). NCCN task force report: oral chemotherapy. Journal of the National Comprehensive Cancer Network, 6 (Suppl 3), 1–14.
  • Weingart SN, Toro J, Spencer J, Duncombe D, Gross A, Bartel S et al. (2010). Medication errors involving oral chemotherapy. Cancer, 116(10), 2455–2464. https://doi.org/10.1002/cncr.25027
  • Waseem H, Ginex PK, Sivakumaran K, DeGennaro GM, Lagler-Clark S, LeFebvre KB et al. (2022). Interventions to support adherence to oral anticancer medications: systematic review and meta-analysis. Oncology Nursing Forum, 49(4), E4–E16. https://doi.org/10.1188/22.ONF.E4-E16
  • Verbrugghe M, Verhaeghe S, Lauwaert K, Beeckman D, Van Hecke A. (2013). Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treatment Reviews, 39(6), 610–621. https://doi.org/10.1016/j.ctrv.2012.12.014
  • Zerillo JA, Goldenberg BA, Kotecha RR, Tewari AK, Jacobson JO, Krzyzanowska MK. (2018). Interventions to improve oral chemotherapy safety and quality: a systematic review. JAMA Oncology, 4(1), 105–117. https://doi.org/10.1001/jamaoncol.2017.06 25

Examination of Articles on Oral Chemotherapy in the Field of Nursing in the Last 10 Years in Türkiye

Year 2023, , 791 - 799, 15.10.2023
https://doi.org/10.38108/ouhcd.1263211

Abstract

In this study, it was aimed to examine the articles on oral chemotherapy published between 2012-2023 in the field of nursing in Turkey. The research was conducted as a retrospective type descriptive based on the literature. It was searched from Google Scholar, Turkish Medline and Pubmed databases using the keywords "oral chemotherapy, nursing" in Turkish and English. 11 articles published between 2012-2023 and meeting the inclusion criteria were examined. It was determined that 81.8% of the articles were research articles and 18.2% were compilations. 54.5% of the articles were published in national journals, 45.5% in international journals and 63.6% in English. 45.5% of the studies examined drug compliance in oral chemotherapy. 100% of the studies were conducted with patients. Studies with health professionals and family members who care for patients could not be reached as the sample population in the studies. It is thought that determining the awareness, knowledge, clinical practices and support needs of these groups in terms of patient care quality will guide evidence-based studies.

References

  • Aisner J. (2007). Overview of the changing paradigm in cancer treatment: oral chemotherapy. American Journal of Health-System Pharmacy, 64(Suppl 5), 4–7. https://doi.org/10.2146/ajhp070035
  • Algethami AA, Alshamrani MA, AlHarbi AM, AlAzmi AA, Khan MA, AlHadidi RA. (2021). Evaluation of handling, storage, and disposal practices of oral anticancer medications among cancer patients and their caregivers at home setting in the Princess Noorah Oncology Center. Journal of Oncology Pharmacy Practice, 27(1), 20–25. https://doi.org/10.1177/ 1078155220908937
  • Bağçivan G, Akbayrak N. (2015). Development and psychometric testing of the Turkish-version oral chemotherapy adherence scale. The Journal of Nursing Research, 23(4), 243–251. https://doi.org/10.1097/ JNR.0000000000000101
  • Banna GL, Collovà E, Gebbia V, Lipari H, Giuffrida P, Cavallaro S et al. (2010). Anticancer oral therapy: emerging related issues. Cancer Treatment Reviews, 36(8), 595–605. https://doi.org/10.1016/j.ctrv.2010.04.005
  • Barillet M, Prevost V, Joly F, Clarisse B. (2015). Oral antineoplastic agents: how do we care about adherence?. British Journal of Clinical Pharmacology, 80(6), 1289–1302. https://doi.org/10.1111/bcp.12734
  • Chen Y, Wu X, Xian X, Zhang Y, Gong N, Qin H et al. (2020). Adherence to oral chemotherapy among colorectal cancer patients: a longitudinal study. European Journal of Oncology Nursing, 48, 101822. https://doi.org/10.1016/j.ejon.2020.101822
  • Christiansen N, Taylor KM, Duggan C. (2008). Oral chemotherapy in paediatric oncology in the UK: problems, perceptions and information needs of parents. Pharmacy World & Science, 30(5), 550–555. https://doi.org/10.1007/s11096-008-9208-5
  • Cin S, Karadakovan A. (2017). Oral kemoterapi tedavisi alan hastalara verilecek planlı eğitimin tedaviye uyma ve yaşam kalitesi üzerine etkisinin incelenmesi. E-Sağlık Hemşirelik Dergisi, 25(7), 10-19.
  • Cirillo M, Carlucci L, Legramandi L, Baldini E, Sacco C, Zagonel V et al. (2020). Oral anticancer therapy project: clinical utility of a specific home care nursing programme on behalf of Italian Association of Medical Oncology (AIOM). Journal of Clinical Nursing, 29(1-2), 119–129. https://doi.org/10.1111 /jocn.15064
  • Çakmak HS, Akdemir N. (2020). Knowledge and implication about oral antineoplastics drugs use of cancer patients. Turkish Journal of Clinics and Laboratory, 11(5), 387-392. https://doi.org/10.18663/tjcl.674152
  • Gandhi S, Day L, Paramsothy T, Giotis A, Ford M, Boudreau A et al. (2015). Oral anticancer medication adherence, toxicity reporting, and counseling: a study comparing health care providers and patients. Journal of Oncology Practice, 11(6), 498–504. https://doi.org/10.1200/JOP.2015.004572
  • Geynisman DM, Wickersham KE. (2013). Adherence to targeted oral anticancer medications. Discovery Medicine, 15 (83), 231-41.
  • Goodin S, Griffith N, Chen B, Chuk K, Daouphars M, Doreau C et al. (2011). Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panel. Journal of Oncology Practice, 7(1), 7–12. https://doi.org/10.1200/jop.2010.000068
  • Gönderen Çakmak HS, Kapucu S. (2021). The effect of educational follow-up with the motivational interview technique on self-efficacy and drug adherence in cancer patients using oral chemotherapy treatment: a randomized controlled trial. Seminars in Oncology Nursing, 37(2), 151140. https://doi.org/10.1016/j.soncn.2021.151140
  • Gönderen Çakmak HS, Kapucu S. (2018). Oral antikanser ilaç kullanan kanser hastalarında telefon ile yapılan izlemin ilaç uyumuna etkisi: sistematik derleme. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi, 5(3), 230-246. https://doi.org/10.31125/hunhemsire.500799
  • Gönderen Çakmak HS, Uncu D. (2020). Relationship between health literacy and medication adherence of Turkish cancer patients receiving oral chemotherapy. Asia-Pacific Journal of Oncology Nursing, 7(4), 365–369. https://doi.org/10.4103/apjon.apjon_30_20
  • Hirao C, Mikoshiba N, Shibuta T, Yamahana R, Kawakami A, Tateishi R et al. (2017). Adherence to oral chemotherapy medications among gastroenterological cancer patients visiting an outpatient clinic. Japanese Journal of Clinical Oncology, 47(9), 786–794. https://doi.org/10.1093/jjco/hyx087
  • Huff C. (2020). Oral chemotherapy: a home safety educational framework for healthcare providers, patients, and caregivers. Clinical Journal of Oncology Nursing, 24(1), 22–30. https://doi.org/10.1188/20.CJON.22-30
  • Irshad S, Maısey N. (2010). Considerations when choosing oral chemotherapy: identifying and responding to patient need. European Journal of Cancer Care, 19, 5–11.
  • Jacobs JM, Ream ME, Pensak N, Nisotel LE, Fishbein JN, MacDonald JJ et al. (2019). Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life. Journal of the National Comprehensive Cancer Network, 17(3), 221–228. https://doi.org/10.6004/jnccn.2018.7098
  • Johnson LA. (2015). Factors influencing oral adherence: qualitative metasummary and triangulation with quantitative evidence. Clinical Journal of Oncology Nursing, 19(Suppl 3), 6–30. https://doi.org/10.1188/15.S1.CJON.6-30
  • Kahn JM, Athale UH, Clavell LA, Cole PD, Leclerc JM, Laverdiere C et al. (2017). How variable ıs our delivery of information? Approaches to patient education about oral chemotherapy in the pediatric oncology clinic. Journal of Pediatric Health Care, 31(1), 1–6. https://doi.org/10.1016/j.pedhc.2016.06.004
  • Karaaslan Eşer A, Ayaz Alkaya S. (2021). The effect of a mobile application on treatment adherence and symptom management in patients using oral anticancer agents: a randomized controlled trial. European Journal of Oncology Nursing, 52, 101969. https://doi.org/10.1016/j.ejon.2021.101969
  • Krikorian S, Pories S, Tataronis G, Caughey T, Chervinsky K, Lotz M et al. (2019). Adherence to oral chemotherapy: challenges and opportunities. Journal of Oncology Pharmacy Practice, 25(7), 1590–1598. https://doi.org/10.1177/1078155218800384
  • Kutlutürkan S, Sözeri E. (2016). Oral kemoterapi uygulamasında anahtar unsur: hasta uyumu. Van Tıp Dergisi, 23(3), 290-293.
  • Kutlutürkan S, Yurtal Ö, Kırca K. (2018). Opinions and experiences of patients receiving oral chemotherapy: a qualitative study. Annals of Oncology, 29(8), 686. https://doi.org/10.1093/annonc/mdy276.014
  • Lin C, Clark R, Tu P, Bosworth HB, Zullig LL. (2017). Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers. Breast Cancer Research and Treatment, 165(2), 247–260. https://doi.org/10.1007/s10549-017-4317-2
  • Moore S. (2007). Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nursing, 30(2), 112–124. https://doi.org/10.1097/01.NCC.0000265009.33053.2d
  • Özkaraman A, Orlu N, Atalay HÖ, Babadağ B, Yılmaz H, Dinçer M ve ark. (2017). Oral kemoterapi alan hastalarda yaşanılan güçlükler ve ilaç uyumunun değerlendirilmesi. Bakırköy Tıp Dergisi, 13(2), 91-97. https://doi.org/10.5350/BTDMJB201713206
  • Shinnick S. (2020). Assessment of the role of the pediatric nurse in patient education and follow-up of patients receiving oral anticancer treatment. Journal of Pediatric Oncology Nursing, 37(1), 46–54. https://doi.org/10.1177/1043454219871081
  • Solano M, Daguindau E, Faure C, Loriod P, Pain C, Maes AC et al. (2021). Oral therapy adherence and satisfaction in patients with multiple myeloma. Annals of Hematology, 100(7), 1803–1813. https://doi.org/10.1007/s00277-021-04543-7
  • Sun J, Wei Q, Zhou Y, Wang J, Liu Q, Xu H. (2017). A systematic analysis of FDA-approved anticancer drugs. BMC Systems Biology, 11(Suppl 5), 87. https://doi.org/10.1186/s12918-017-0464-7
  • Talens A, Guilabert M, Lumbreras B, Aznar MT, López-Pintor E. (2021). Medication experience and adherence to oral chemotherapy: a qualitative study of patients' and health professionals' perspectives. International Journal of Environmental Research and Public Health, 18(8), 4266. https://doi.org/10.3390/ijerph18084266
  • Tokdemir G, Kav S. (2017). The effect of structured education to patients receiving oral agents for cancer treatment on medication adherence and self-efficacy. Asia-Pacific Journal of Oncology Nursing, 4(4), 290–298. https://doi.org/10.4103/apjon.apjon_35_17
  • Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM et al. (2008). NCCN task force report: oral chemotherapy. Journal of the National Comprehensive Cancer Network, 6 (Suppl 3), 1–14.
  • Weingart SN, Toro J, Spencer J, Duncombe D, Gross A, Bartel S et al. (2010). Medication errors involving oral chemotherapy. Cancer, 116(10), 2455–2464. https://doi.org/10.1002/cncr.25027
  • Waseem H, Ginex PK, Sivakumaran K, DeGennaro GM, Lagler-Clark S, LeFebvre KB et al. (2022). Interventions to support adherence to oral anticancer medications: systematic review and meta-analysis. Oncology Nursing Forum, 49(4), E4–E16. https://doi.org/10.1188/22.ONF.E4-E16
  • Verbrugghe M, Verhaeghe S, Lauwaert K, Beeckman D, Van Hecke A. (2013). Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treatment Reviews, 39(6), 610–621. https://doi.org/10.1016/j.ctrv.2012.12.014
  • Zerillo JA, Goldenberg BA, Kotecha RR, Tewari AK, Jacobson JO, Krzyzanowska MK. (2018). Interventions to improve oral chemotherapy safety and quality: a systematic review. JAMA Oncology, 4(1), 105–117. https://doi.org/10.1001/jamaoncol.2017.06 25
There are 39 citations in total.

Details

Primary Language Turkish
Subjects Nursing, ​Internal Diseases Nursing​
Journal Section Review
Authors

Baise Bicav 0000-0003-0648-9911

Sevinç Kutlutürkan 0000-0002-3230-0775

Early Pub Date October 15, 2023
Publication Date October 15, 2023
Submission Date March 10, 2023
Published in Issue Year 2023

Cite

APA Bicav, B., & Kutlutürkan, S. (2023). Türkiye’de Son 10 Yılda Hemşirelik Alanında Yapılan Oral Kemoterapi Konulu Makalelerin İncelenmesi. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi, 6(3), 791-799. https://doi.org/10.38108/ouhcd.1263211